Back

Annals of the Rheumatic Diseases

23 training papers 2019-06-25 – 2026-03-07

Top medRxiv preprints most likely to be published in this journal, ranked by match strength.

1
Phenotype-specific associations of mosaic chromosomal alterations in systemic sclerosis
2026-03-03 rheumatology 10.64898/2026.03.02.26347384
Top 0.1% (20.7%)
Show abstract

ObjectivesMosaic chromosomal alterations (mCAs) increase with age and are associated with many diseases, including autoimmune diseases. The associations between mCAs and systemic sclerosis (SSc) and its clinical subtypes have not been explored. MethodsWe recruited study subjects from two independent datasets (Set 1: 635 SSc, 4,401 controls; Set 2: 347 SSc, 2,170 controls) and detected mCAs (Loss, LOH, Gain, and mLOX) from their peripheral blood samples. Logistic regression analyses were conduct...

2
Longitudinal peripheral blood multi-omic profiling in seropositive individuals identifies immune endotypes and predictive models for future rheumatoid arthritis conversion
2026-02-17 rheumatology 10.64898/2026.02.12.26346058
Top 0.1% (20.3%)
Show abstract

Individuals who have serum elevations of anti-cyclic citrullinated protein (anti-CCP) antibodies are at risk for developing rheumatoid arthritis (RA), yet immunologic factors that lead to a transition from pre- to clinical RA remain unclear. Here, we used materials from anti-CCP antibody-positive individuals enrolled in a clinical trial that evaluated the efficacy of hydroxychloroquine to prevent clinical RA, and performed multi-modal single-cell profiling (transcriptome, surface proteins, T/B-c...

3
Expanding the clinical spectrum of autoimmune inflammatory myopathies with prominent B cell aggregates: a case series
2026-03-03 rheumatology 10.64898/2026.03.01.26347357
Top 0.2% (19.2%)
Show abstract

Autoimmune inflammatory myopathies (AIM) with prominent B cell aggregates (BCM) on muscle biopsy is an uncommon finding. We aimed to compare the characteristics and clinical course of patients with BCM on muscle biopsy to those without and characterize B cell infiltrates in the muscle of these patients. We performed a retrospective study of subjects with AIM in the Canada Inflammatory Myopathy Study (CIMS) cohort to identify cases with BCM on muscle biopsy, which was defined as [≥]30 CD20+ c...

4
Spatial transcriptomics reveals mechanism of autoimmunity driven by internalized autoantibodies
2026-02-17 rheumatology 10.64898/2026.02.14.26346329
Top 0.3% (13.7%)
Show abstract

Autoantibody internalization has been implicated in autoimmune disease pathogenesis, yet its mechanisms, and generality across different diseases, cell types, and affected tissues remain poorly defined. Using bulk RNA sequencing, we identified reproducible, autoantibody-specific transcriptomic signatures consistent with autoantigen dysfunction in muscle biopsies from patients with anti-Mi2 dermatomyositis and anti-PM/Scl scleromyositis across independent cohorts. Electroporation of purified pati...

5
Deep learning-derived quantitative interstitial abnormalities in early rheumatoid arthritis and healthy controls: A multicenter, prospective cross-sectional study
2026-02-22 rheumatology 10.64898/2026.02.20.26346723
Top 0.4% (13.4%)
Show abstract

ObjectiveQuantitative computed tomography (QCT) can automatically quantify parenchymal abnormalities on chest CT imaging using deep learning. We leveraged QCT to detect pulmonary abnormalities in patients with early rheumatoid arthritis (RA) compared to healthy controls. MethodsWe analyzed high-resolution CT chest imaging from participants with early RA in the prospective, multicenter, SAIL-RA study and healthy non-smoking controls from the COPDGene study. A deep learning classifier quantified ...

6
NHAPL analysis of glycoRNA reveals sialic acid-containing glycosylated mRNA 3UTRs and enables sensitive SLE diagnostics
2026-02-09 rheumatology 10.64898/2026.02.05.26345357
Top 0.4% (12.2%)
Show abstract

GlycoRNA, newly identified RNA molecules bearing glycan modifications on cell membranes, is implicated in cell communication and immune regulation. However, current technological limitations impede a thorough elucidation of their biological roles and clinical significance. Here, we developed Nucleotides Hybridization and Aptamer-based Proximity Ligation (NHAPL), a homogeneous assay enabling sensitive and quantitative glycoRNA analysis from 160pg total cell RNA and 1{micro}l serum. NHAPL integrat...

7
Clinical Evaluation of a Digital Biomarker for Joint Swelling in Inflammatory Arthritis based on Automated Quantification of Dorsal Finger Fold Patterns
2026-02-27 rheumatology 10.64898/2026.02.26.26347165
Top 0.4% (10.2%)
Show abstract

ObjectiveTo clinically evaluate a digital biomarker, the Finger Fold Index (FFI), derived from the ratio of joint diameter to finger fold surface area in hand photographs, for assessing joint swelling in inflammatory arthritis. MethodsSmartphone hand photographs from two routine care cohorts of patients with rheumatoid (RA) and psoriatic arthritis (PsA) were analyzed using a machine learning pipeline for automated detection and processing of proximal interphalangeal (PIP) joints. The FFI was cl...

8
Airborne particulate matter enhances with monosodium urate crystals the secretion of IL-1b by human immune cells
2026-03-02 rheumatology 10.64898/2026.02.26.26347218
Top 0.5% (9.9%)
Show abstract

Gout is driven by an interleukin-1{beta}-mediated intense innate immune reaction to monosodium urate (MSU) crystals (MSUc). In cell culture models of inflammatory gout there is a synergistic effect of phagocytosis of MSUc and TLR2 and TLR4 activation by agonists such as free fatty acid and lipopolysaccharide (LPS) in NLRP3-inflammasome activation and IL-1{beta} secretion. A substantial number of gout patients do not report a dietary trigger, and observational studies associate airborne particula...

9
Supervised yogic intervention improves pain, cortical excitability and flexibility in fibromyalgia patients: Objective evidence based of journey from case control study to randomized controlled trial
2026-02-24 rheumatology 10.64898/2026.02.20.26346039
Top 0.5% (9.9%)
Show abstract

Background and AimFibromyalgia is an idiopathic chronic widespread pain syndrome affecting 2-4% of the general population globally. Besides widespread fibromyalgia pain, morning stiffness, associated neurologic as well as sleep problems are also reported. Disease is more prevalent in females of middle-age group with low socioeconomic status, thus deteriorating overall productivity and psychosocial health. There is no permanent cure of the disease. This study aimed to explore, validate and assess...

10
Genetically informed search for potential osteoarthritis drug targets across the proteome
2026-02-11 rheumatology 10.64898/2026.02.10.26345885
Top 0.5% (8.6%)
Show abstract

BackgroundOsteoarthritis (OA) is a leading cause of disability worldwide, yet no licensed therapies can prevent or slow its progression. We aimed to identify potential targets for disease-modifying OA drugs (DMOADs) by integrating genetic and differential protein expression (DPE) evidence. MethodsWe evaluated genetically predicted perturbations of plasma protein levels using cis-protein quantitative trait loci (cis-pQTLs) across three large European cohorts (UK Biobank Pharma Proteomics Project...

11
A Common Missense Variant, W335S, in β2-Glycoprotein I (APOH) is Associated with Increased Autoantibody Levels but Reduced Venous Thromboembolism Risk
2026-03-05 rheumatology 10.64898/2026.03.04.26347632
Top 0.5% (8.4%)
Show abstract

Anti-{beta}2-glycoprotein I (anti-{beta}2GPI) antibodies are central to the pathogenesis of antiphospholipid syndrome (APS), an autoimmune disease characterized by a strong predisposition to venous thromboembolism (VTE). In this study, we conducted a multi-ancestry genome-wide association study (GWAS) of quantitative total anti-{beta}2GPI levels in 5,969 participants enrolled in the Multi-Ethnic Study of Atherosclerosis (MESA) and identified a genome-wide significant association at the APOH locu...

12
Structural phenotypes of osteoarthritis are clinically and genetically distinct: findings from 59,539 UK Biobank participants
2026-02-10 rheumatology 10.64898/2026.02.08.26345686
Top 0.5% (7.2%)
Show abstract

OBJECTIVESOsteoarthritis is a heterogeneous disease, with diverse structural patterns likely reflecting distinct genetic drivers. Robust, data-driven methods to identify and characterise such phenotypes are lacking. This study leveraged the UK Biobank to define machine learning-derived structural osteoarthritis phenotypes and evaluate their clinical and genetic profiles. METHODSMachine learning models were applied to knee and hip DXA scans to derive osteophyte area, minimum joint space width, a...

13
Harnessing AI and social media to understand real-world patient experiences in systemic lupus erythematosus
2026-02-22 rheumatology 10.64898/2026.02.20.26346724
Top 0.6% (6.5%)
Show abstract

ObjectiveTo apply large language models (LLMs) to Reddit posts referencing systemic lupus erythematosus (SLE) to identify patient-expressed unmet medical needs, symptom experiences, and healthcare challenges, demonstrating how AI-enabled social media listening complements traditional patient-experience research. MethodsWe extracted 4,633 posts from ten SLE-related or health-focused Reddit communities using the public Reddit API (October-November 2025). After removing duplicates, promotional con...

14
IL-6 Receptor Antagonists and Severe Post-COVID-19 Outcomes: An Emulated Target Trial
2026-03-02 epidemiology 10.64898/2026.02.27.26347274
Top 0.6% (5.2%)
Show abstract

BackgroundInterleukin-6 (IL-6) is a cytokine that plays a key role in systemic hyperinflammation and may mediate the relationship between acute COVID-19 and severe long-term outcomes such as Long COVID or death. IL-6 modulating drugs may reduce patients risk of severe post-COVID-19 outcomes. MethodsWe conducted an emulated target trial in a retrospective cohort of patients with moderate-to-severe rheumatoid arthritis who were prescribed IL-6 receptor antagonists (sarilumab or tocilizumab, poole...

15
Biomarkers for Atherosclerotic Cardiovascular Events in Rheumatoid Arthritis: Towards Validation of a Biomarker-Enhanced Risk Model
2026-02-20 cardiovascular medicine 10.64898/2026.02.18.26346592
Top 0.7% (3.7%)
Show abstract

BackgroundCardiovascular (CV) disease risk is increased in rheumatoid arthritis (RA) and is the leading cause of mortality. Improved CV risk stratification tools in RA could enhance use of preventative care and improve outcomes. MethodsWe previously studied biomarkers of CV disease - adiponectin, hsCRP, Lp(a), osteoprotegerin (OPG), high-sensitivity cardiac troponin T (hsTnT), serum amyloid A (SAA), YKL-40, soluble TNF receptor1 (sTNFR1) -- that were associated with CV risk. In the current stud...

16
Plasma proteome signatures in sickle cell anaemia and effect of hydroxyurea treatment
2026-02-10 hematology 10.64898/2026.02.08.26345875
Top 0.9% (1.4%)
Show abstract

BackgroundSickle Cell Anaemia (SCA), a genetic blood disorder caused by a single mutation in the beta globin gene, displays a highly variable clinical course. Hydroxyurea (HU), an effective treatment, has an unclear mechanism of action. Plasma proteins can act as biomarkers for understanding disease states and response to HU treatment in SCA patients. MethodsPlasma proteome profiling of 31 healthy individuals and 76 SCA patients, including those with and without HU treatment, was performed usin...

17
Genetic insights into immunothrombosis: from shared loci to repurposed drugs for autoimmune and thrombotic diseases
2026-03-03 hematology 10.64898/2026.02.28.26346627
Top 0.9% (1.4%)
Show abstract

ObjectiveAutoimmune diseases (ADs) markedly elevate venous thromboembolism (VTE) risk, yet the shared genetic architecture and tissue-specific regulatory mechanisms of this "Autoimmune-Thrombotic Axis" remain poorly defined. We aimed to characterize the genomic landscape of immunothrombosis to identify causal links and therapeutic targets. Approach and ResultsWe integrated large-scale GWAS data for VTE and 16 ADs using a multi-omics framework, including pleiotropy scanning, local genetic correl...

18
High-dimensional CyTOF profiling reveals distinct maternal and fetal immune landscapes in gestational diabetes mellitus
2026-02-18 allergy and immunology 10.64898/2026.02.17.26346459
Top 1% (0.7%)
Show abstract

AimsGestational diabetes mellitus (GDM) is the most common pregnancy-related medical complication. GDM is linked to aberrant immune responses in both mothers and offsprings, specifically, the subsequent development of inflammatory diseases. Whereas prior research has focused on specific immune cell subsets, a comprehensive overview of the impacts of GDM on maternal and fetal immune landscape is lacking. Here, we aim to comprehensively decipher how GDM modulates various immune cell populations in...

19
Adenoviral Vectors Overcome Immunosuppression Via Antigen Persistence and Metabolic Reprogramming
2026-03-06 allergy and immunology 10.64898/2026.03.05.26347734
Top 1% (0.7%)
Show abstract

Vaccination frequently elicits suboptimal immunogenicity in organ transplant recipients, particularly those on long-term immunosuppressive therapy, highlighting the need for improved understanding of immunosuppression mechanisms and optimized vaccination strategies. This study enrolled a cohort of 132 individuals and observed significantly lower antibody levels in kidney transplant recipients (KTRs) compared to non-transplant controls (non-KTRs). Antibody levels were inversely associated with bo...

20
Human RIG-I Antiviral Deficiency Caused by a Dominant-Negative Variant Locked in a Signaling-Inactive State
2026-03-06 allergy and immunology 10.64898/2026.03.02.26347088
Top 1% (0.4%)
Show abstract

RIG-I is a cytosolic immune receptor that provides the first line of defense by detecting viral RNA and triggering antiviral responses. Its physiological role in humans remains unclear, as no patients with complete RIG-I deficiency have yet been reported. We identified a critically ill COVID-19 patient with severe RIG-I deficiency caused by heterozygous RIG-I G731R, a novel dominant loss-of-function variant. The G731R mutation in helicase motif VI disrupts the arginine finger, impairing the ATPa...